Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease

Overview of attention for article published in Frontiers in Neurology, March 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 13,081 followers.

RT @TheMOGProject: ‘Serum & CSF biomarkers in #NMOSD & #MOGAD.’ 👇🏻👇🏻 https://t.co/RLkLpwPx5X

11 Apr 2022

Reply Repost Favourite

RT @TheMOGProject: ‘Serum & CSF biomarkers in #NMOSD & #MOGAD.’ 👇🏻👇🏻 https://t.co/RLkLpwPx5X

11 Apr 2022

Reply Repost Favourite

‘Serum & CSF biomarkers in #NMOSD & #MOGAD.’ 👇🏻👇🏻 https://t.co/RLkLpwPx5X

11 Apr 2022

Reply Repost Favourite

New Research: Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease: The term neuromyelitis optica spectrum disorder (NMOSD) describes a group of… https://t.co/5As7hviD

23 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.